Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Loxo Oncology Inc (NASDAQ:LOXO)

48.14
Delayed Data
As of 11:02am ET
 -0.14 / -0.29%
Today’s Change
17.14
Today|||52-Week Range
49.80
+49.90%
Year-to-Date
No recent news for Loxo Oncology Inc.

Today’s Trading

Previous close48.28
Today’s open48.27
Day’s range48.00 - 48.47
Volume22,411
Average volume (3 months)276,113
Market cap$1.3B
Dividend yield--
Data as of 11:02am ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)-63.21%
Earnings growth (this year)-9.84%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.04

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...-0.02-0.07%
GBTGlobal Blood Therape...+0.10+0.34%
RGENRepligen Corp+0.32+0.89%
XNCRXencor Inc+0.38+1.48%
Data as of 11:16am ET, 04/27/2017

Financials

Next reporting dateMay 18, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$0.00
Annual profit (last year)-$72.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
Executive Director-
Business Operations
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts


Search for Jobs